@article{article, title = {{Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both}}, url = {{http://eprints.whiterose.ac.uk/101667/ }}, year = {{2016}}, month = {{4}}, author = {{James ND and Pirrie SJ and Pope AM and Barton D and Andronis L and Goranitis I and Collins S and Daunton A and McLaren D and O鈥橲ullivan J and Parker C et al}}, doi = {{10.1001/jamaoncol.2015.5570}}, volume = {{2}}, journal = {{JAMA Oncology}}, issue = {{4}}, pages = {{493-493}}, note = {{Accessed on 2025/08/30}}}